# DESCRIPTION

## FIELD OF INVENTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF INVENTION

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

### Definitions

### Methods

### BAD Pathway Expression

### Analysis of Genomic and Chemo-Sensitivity Data for NCI60 Cancer Cell Lines

### Modulating BAD Phosphorylation by siRNA Transfection

### MTS Cell Proliferation Assays

### Western Blot Analysis

### Immunofluorescence Microscopy

### Antibodies

## Results

### BAD Pathway Expression is Associated with Cancer Development, Progression, Relapse, and Survival

### BAD Pathway Expression is Associated with In-Vitro Sensitivity to a Broad Range of Cytotoxic Drugs

### BAD Pathway Expression is Associated with In Vitro Levels of Phosphorylated BAD Protein

### Modulation of BAD Phosphorylation Affects Proliferation of Cancer Cell Lines

### BAD Phosphorylation Status and Cancer Development

## Conclusion

